Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CMCSA vs MRNA✓SelectedUSD · MRNACMCSA vs MRNA performance historyLatest closeAs of-1.51%11/19
Stock and ETF performance explorer

CMCSA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-38.7%
MRNA return
-25.6%
Excess return
-13.1%
Maximum drawdown
-49.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.5%+1.3%-2.8%-1.5%
7D+0.2%-13.8%+14.1%+0.7%
30D+11.2%-17.7%+28.8%+11.7%
3M-5.1%+14.3%-19.4%-5.9%
6M+3.2%+336.0%-332.8%-6.1%
YTD-6.5%+575.9%-582.4%-18.6%
1Y+4.0%+724.4%-720.4%-11.2%
3Y-29.6%+160.8%-190.3%-35.8%
All-38.7%-25.6%-13.1%-42.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling